BR100 Increased By (1.42%)
BR30 Increased By (1.31%)
KSE100 Increased By (1.2%)
KSE30 Increased By (1.25%)
AGHA 7.84 Increased By ▲ 0.09 (1.16%)
BECO 5.24 Increased By ▲ 0.05 (0.96%)
BML 57.90 Decreased By ▼ -0.76 (-1.3%)
BOP 34.40 Increased By ▲ 0.71 (2.11%)
CNERGY 10.90 Increased By ▲ 0.29 (2.73%)
CSIL 5.45 Increased By ▲ 0.15 (2.83%)
FCCL 55.00 Increased By ▲ 1.26 (2.34%)
FFL 16.80 Increased By ▲ 0.34 (2.07%)
FNEL 1.25 Increased By ▲ 0.03 (2.46%)
KEL 7.46 Increased By ▲ 0.18 (2.47%)
KOSM 5.84 Increased By ▲ 0.20 (3.55%)
LOTCHEM 29.98 Increased By ▲ 0.33 (1.11%)
MLCF 96.64 Increased By ▲ 0.28 (0.29%)
NBP 205.86 Increased By ▲ 2.33 (1.14%)
NCPL 57.95 Increased By ▲ 1.10 (1.93%)
NPL 68.89 Increased By ▲ 1.58 (2.35%)
OGDC 321.00 Increased By ▲ 2.78 (0.87%)
PACE 10.89 Increased By ▲ 0.26 (2.45%)
PAEL 43.22 Increased By ▲ 1.45 (3.47%)
PIBTL 17.10 Increased By ▲ 0.29 (1.73%)
PPL 223.50 Increased By ▲ 3.33 (1.51%)
PRL 52.30 Increased By ▲ 3.25 (6.63%)
PTC 71.30 Increased By ▲ 1.29 (1.84%)
SSGC 29.67 Increased By ▲ 0.53 (1.82%)
TBL 9.92 Increased By ▲ 0.15 (1.54%)
TELE 8.97 Increased By ▲ 0.15 (1.7%)
TPL 17.82 Increased By ▲ 0.65 (3.79%)
TPLP 12.95 Increased By ▲ 0.44 (3.52%)
TREET 22.93 Increased By ▲ 0.34 (1.51%)
TRG 60.30 Increased By ▲ 0.08 (0.13%)

ISLAMABAD: Former prime minister and founding chairman of Pakistan Tehreek-i-Insaf (PTI), Imran Khan, was brought to the Pakistan Institute of Medical Sciences (Pims) for a scheduled follow-up of his ongoing eye treatment.

Hospital officials said he received the second dose of an anti-VEGF intravitreal injection on February 24 as part of his treatment plan. Before the procedure, he was examined by a panel of specialists, including a consultant cardiologist who conducted an echocardiography and ECG, both of which were reported to be normal, along with an assessment by a consultant physician. Doctors described him as clinically stable before the intervention.

The injection was administered under standard operating protocols in the operation theatre, with monitoring and precautionary measures in place. The procedure was carried out by a consultant ophthalmologist and a vitreo-retinal surgeon from Pims, in collaboration with a specialist from Al-Shifa Eye Hospital. The treatment was performed as a day-care surgery.

Officials said he remained vitally stable before, during, and after the procedure, and was later discharged with post-procedure care instructions and follow-up advice.

In a statement issued early Tuesday, Pims hospital said Khan was examined by a board of specialists, including a consultant cardiologist who performed an echocardiography and ECG. “Mr. Imran Khan was found to be clinically stable,” the hospital said, adding that a second dose of an intravitreal Anti-VEGF injection was administered by surgeons from PIMS and Al-Shifa Eye Hospital. “The procedure was performed as day-care surgery. During the course of his stay, he remained vitally stable before, during, and after the procedure, and was discharged with instructions for care, follow-up advice, and documentation,” the statement added.

Copyright Business Recorder, 2026

Comments

200 characters remaining